2415 — MedSci Healthcare Holdings Cashflow Statement
0.000.00%
- HK$562.31m
- -HK$717.46m
- CNY260.62m
- 75
- 72
- 50
- 77
Annual cashflow statement for MedSci Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 33.2 | -147 | -96.3 | 60.5 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -1.54 | 200 | 108 | -15.9 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 17.5 | -23.9 | -34.3 | -14.9 | — |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 56.2 | 37.4 | -14 | 38 | — |
Capital Expenditures | -1.11 | -0.889 | -2.16 | -1.95 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 32.5 | -1.15 | 0.031 | -493 | — |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 31.4 | -2.03 | -2.13 | -495 | — |
Financing Cash Flow Items | 0 | -3.88 | 0 | 520 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 93.1 | 286 | -7.52 | 471 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 181 | 319 | 3.26 | 29.3 | — |